Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma

We previously reported our experience in treating 56 patients with metastatic melanoma using a human anti-cytotoxic T-lymphocyte antigen 4 (CTLA-4) antibody. Durable tumor regressions were seen that correlated with the induction of autoimmune toxicities. In this study, we treated 46 additional patie...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Maker, Ajay V., Yang, James C., Sherry, Richard M., Topalian, Suzanne L., Kammula, Udai S., Royal, Richard E., Hughes, Marybeth, Yellin, Michael J., Haworth, Leah R., Levy, Catherine, Allen, Tamika, Mavroukakis, Sharon A., Attia, Peter, Rosenberg, Steven A.
Format: Artigo
Jezik:Inglês
Izdano: 2006
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2134804/
https://ncbi.nlm.nih.gov/pubmed/16799341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.cji.0000208259.73167.58
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki